Pramipexole, Levodopa Both Effective for Early Parkinson's

"A four-year clinical trial comparing pramipexole and levodopa as initial dopaminergic therapy in Parkinson's disease found different adverse effect and efficacy profiles for the two drugs, but concludes both are 'reasonable options' for early treatment of the disease."

What kind of agonist is Pramipexole?